Running a UK life science business in the COVID-19 pandemic Webinar

** Please Note - Time of webinar is 11am, not 2pm as advertised **  

 

What to consider and what support is available?

Join us this Thursday for another webinar from the BIA, this time looking at running a UK life science business in the COVID-19 pandemic - what to consider and what support is available?

The webinar will also provide a brief update on what our sector is doing to support the UK and global effort against COVID-19

Speakers
Steve Bates

Chief Executive Officer

BIA

Steve Bates has been the CEO of the UK Bioindustry Association since 2012. He currently chairs the International Council of Biotech Associations and has been a Board member of Europabio since 2015. Steve is the visible face of the vibrant UK life sciences industry to government and media. He sits on the UK’s Life Sciences Council and Life Sciences Industrial Strategy Implementation Board. Steve has championed with government effective industrial incentives like the Biomedical Cataylst which have crowded-in private sector investment into UK SMES. He has forged links for the sector across the USA, Europe and in China. In his time at the BIA Steve has developed new member groups focused on cell and gene therapy, genomics and engineered biology. A strong advocate of partnership working, Steve champions sector collaboration with research charities and academia. Proud to lead an organisation with a diverse Board with over 40% female representation, Steve is committed to next generation talent and developing the skills needed for the sector to flourish. Before the BIA, Steve worked for Genzyme and as an advisor to the UK Government of Tony Blair. He was made OBE for services to innovation in 2017.

Michael Warren

Strategic Policy Advisor

BIA

Michael joined the BIA in September to lead our policy and public affairs work on Brexit. He has extensive experience spanning a wide range of senior government and communications roles, most recently as a member of the executive team at Innovate UK, the UK’s innovation agency.

Dr Martin Turner

Policy and Projects Manager

BIA

Martin joined the BIA in April 2016 as Policy and Projects Manager. He is responsible for innovation policy and industrial strategy. He also provides the secretariat for the BIA’s Finance and Tax Advisory Committee and the Intellectual Property Advisory Committee.

Martin has 5 years’ experience in policy and public affairs and has worked at the Royal Society, the Campaign for Science and Engineering, and the Association of Medical Research Charities. Before embarking on a career in policy, Martin completed a PhD in molecular biology at the University of Sheffield, where he also co-founded and was director of an award-winning science communication charity called Science Brainwaves. He has a BSc in molecular biology from the University of Manchester.

Nicky Edwards

Director of External Affairs (Maternity Cover)

BIA

Nicky joined the BIA in December 2018 as Interim Director of External Affairs, providing maternity leave cover for Pamela Learmonth. She is responsible for leading and coordinating the BIA’s work across the full range of policy, public affairs and communications activity.

She has extensive experience of delivering external affairs strategies for national organisations, including more than a decade of leading on policy and public affairs for businesses and membership bodies in the financial and professional services sector.

Dr Eliot Forster

Chief Executive Officer

F-Star

Eliot has more than 25 years of experience in the pharmaceutical and biotechnology industry and previously served as Chief Executive Officer of Immunocore from 2015 and prior to that was Chief Executive Officer of the biotechnology companies Creabilis Therapeutics (now Sienna Biopharmaceuticals) and Solace Pharmaceuticals Inc. Other previous roles include Head of Development and Operations for the EU and Asia at Pfizer. Eliot has held a number of non-executive Director roles and is currently non-executive Chairman of Avacta plc. He is an Honorary Visiting Professor of the Pharmacology and Physiology Department at the University of Liverpool, a Board member of OSCHR (Office for Strategic Coordination of Health Research), MedCity and the National Genomics Board. He holds a PhD from University of Liverpool and an MBA from Henley Management College.

 

Date and time

Date: Thursday 26 March

Time: 11:00 - 11:45

Registration

This webinar is free for members and non members

To register simply click on the 'Register' button at the top right of the page or below

 

 

BIA Annual Supporters

Register